REVANCE THERAPEUTICS INC

CUSIP: 761330AB5 Class: NOTE 1.750% 2/1

D. E. Shaw & Co., Inc.'s Holding History (CIK: 0001009207)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 27,330,000 Value ($000) $26,161 Avg Close — Range —
Q3 2024
Shares 17,230,000 Value ($000) $14,706 Avg Close — Range —
Q2 2024
Shares 40,622,000 Value ($000) $26,709 Avg Close — Range —
Q1 2024
Shares 38,122,000 Value ($000) $28,124 Avg Close — Range —
Q4 2023
Shares 38,122,000 Value ($000) $28,967 Avg Close — Range —
Q3 2023
Shares 38,122,000 Value ($000) $30,650 Avg Close — Range —
Q2 2023
Shares 34,364,000 Value ($000) $36,260 Avg Close — Range —
Q1 2023
Shares 34,364,000 Value ($000) $42,380 Avg Close — Range —